25.20
-0.77 (-2.96%)
| Previous Close | 25.97 |
| Open | 25.95 |
| Volume | 243,691 |
| Avg. Volume (3M) | 228,418 |
| Market Cap | 416,446,240 |
| Price / Sales | 0.400 |
| Price / Book | 43.86 |
| 52 Weeks Range | |
| Earnings Date | 23 Feb 2026 |
| Profit Margin | -126.96% |
| Operating Margin (TTM) | 4.21% |
| Diluted EPS (TTM) | -72.90 |
| Quarterly Revenue Growth (YOY) | -1.40% |
| Total Debt/Equity (MRQ) | 31,271.65% |
| Current Ratio (MRQ) | 1.02 |
| Operating Cash Flow (TTM) | 27.84 M |
| Levered Free Cash Flow (TTM) | 140.38 M |
| Return on Assets (TTM) | 0.83% |
| Return on Equity (TTM) | -198.69% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bearish | Bearish |
| Health Information Services (Global) | Bearish | Bearish | |
| Stock | Claritev Corporation | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | 1.0 |
| Insider Activity | NA |
| Price Volatility | -2.0 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | -0.25 |
|
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 7.81% |
| % Held by Institutions | 82.25% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| H&F Corporate Investors Viii, Ltd. | 30 Sep 2025 | 5,387,858 |
| Cpv Partners, Llc | 30 Sep 2025 | 495,258 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 63.00 (Citigroup, 150.00%) | Buy |
| Median | 48.00 (90.48%) | |
| Low | 33.00 (Wells Fargo, 30.95%) | Hold |
| Average | 48.00 (90.48%) | |
| Total | 1 Buy, 1 Hold | |
| Avg. Price @ Call | 28.94 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Citigroup | 09 Jan 2026 | 63.00 (150.00%) | Buy | 28.94 |
| Wells Fargo | 09 Jan 2026 | 33.00 (30.95%) | Hold | 28.94 |
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 29 Jan 2026 | Announcement | Claritev Corporation Announces Fourth Quarter 2025 Earnings Conference Call |
| 21 Jan 2026 | Announcement | Claritev and Kinetiq Health Enter Into Strategic Agreement to Strengthen Cost Management and Advance Claims Surveillance and Diagnostic Certainty |
| 06 Jan 2026 | Announcement | Claritev Corporation to Present at J.P. Morgan Healthcare Conference |
| 24 Nov 2025 | Announcement | Claritev Corporation Announces Participation at Upcoming Conferences |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |